B
Bioharvest Sciences Inc
OTC:CNVCF
Bioharvest Sciences Inc
OTC:CNVCF
Price:
5.1288
USD
-4.76%
Market Closed
Market Cap:
$87.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bioharvest Sciences Inc
OTC:CNVCF
|
CA |
|
Openn Negotiation Ltd
OTC:OPNNF
|
AU |
|
M
|
Mirae Asset Global REIT Co Ltd
KRX:396690
|
KR |
Cash Flow Statement
Cash Flow Statement
Bioharvest Sciences Inc
Bioharvest Sciences Inc
Currency: USD
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(0)
|
(2)
|
(3)
|
(7)
|
(13)
|
(10)
|
(11)
|
(10)
|
(5)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(8)
|
(13)
|
(18)
|
(16)
|
(17)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Other Non-Cash Items |
(1)
|
1
|
2
|
3
|
9
|
5
|
5
|
3
|
(3)
|
1
|
1
|
2
|
0
|
0
|
(1)
|
3
|
10
|
9
|
10
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Change in Working Capital |
0
|
1
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
(0)
|
1
|
(0)
|
1
|
0
|
(1)
|
(0)
|
(1)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(0)
+43%
|
(2)
-322%
|
(4)
-141%
|
(4)
-14%
|
(6)
-40%
|
(6)
+7%
|
(7)
-18%
|
(8)
-19%
|
(8)
+2%
|
(9)
-13%
|
(9)
-2%
|
(8)
+9%
|
(10)
-14%
|
(8)
+16%
|
(9)
-6%
|
(8)
+1%
|
(7)
+23%
|
(7)
-12%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-600%
|
(0)
-157%
|
(0)
-861%
|
(0)
-148%
|
(1)
-121%
|
(1)
-52%
|
(2)
-14%
|
(2)
-8%
|
(2)
+11%
|
(1)
+14%
|
(1)
+7%
|
(1)
+1%
|
(1)
-4%
|
(1)
-13%
|
(1)
-2%
|
(1)
+10%
|
(3)
-119%
|
(3)
-1%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
1
|
3
|
4
|
9
|
9
|
11
|
11
|
6
|
6
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
5
|
5
|
|
| Net Issuance of Debt |
1
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
5
|
7
|
8
|
10
|
8
|
13
|
12
|
8
|
7
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
2
+17%
|
4
+107%
|
5
+29%
|
9
+82%
|
9
-4%
|
11
+29%
|
11
-4%
|
5
-52%
|
7
+40%
|
6
-19%
|
8
+39%
|
9
+7%
|
11
+31%
|
9
-23%
|
14
+54%
|
13
-5%
|
13
-1%
|
11
-11%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
1
N/A
|
1
+60%
|
2
+50%
|
1
-60%
|
4
+374%
|
2
-63%
|
4
+162%
|
2
-41%
|
(5)
N/A
|
(2)
+51%
|
(5)
-98%
|
(2)
+48%
|
(1)
+59%
|
1
N/A
|
(1)
N/A
|
4
N/A
|
3
-13%
|
3
+7%
|
1
-64%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(0)
+42%
|
(2)
-319%
|
(4)
-149%
|
(5)
-20%
|
(7)
-47%
|
(7)
-1%
|
(8)
-17%
|
(10)
-17%
|
(10)
+3%
|
(10)
-9%
|
(10)
-1%
|
(10)
+8%
|
(11)
-12%
|
(9)
+12%
|
(10)
-5%
|
(10)
+2%
|
(9)
+6%
|
(10)
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
